Editor’s Choice: Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?

Editorial: Towards personalizing PARP inhibitor maintenance therapy for ovarian cancer

Hosted by:
Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology

Featuring:
Rebecca Arhend, University of Alabama at Birmingham, Birmingham, AL, USA
Christina M. Annunziata, American Cancer Society, Atlanta, GA, USA

Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net